Recent studies have raised serious concerns about a potential link between Ozempic (semaglutide) and a rare eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION). NAION is characterized by sudden, painless vision loss due to reduced blood flow to the optic nerve.
A study published in JAMA Ophthalmology reported that patients prescribed semaglutide had a higher risk of developing NAION compared to those not on the medication. Specifically, individuals with diabetes were more than four times as likely, and those with obesity were over seven times as likely, to be diagnosed with NAION when using semaglutide. Read more.
The exact mechanism behind this association remains unclear. Some researchers suggest that rapid reductions in blood sugar levels induced by semaglutide might affect blood flow to the optic nerve, potentially leading to NAION.
While NAION is a relatively rare condition, the potential vision loss as side effect is too severe of a risk to take. laegemiddelstyrelsen.dk
If you're using Ozempic or similar medications and experience any vision changes—such as
blurred vision,
color distortion,
loss of peripheral vision, or
dark spots in your vision
—it's crucial to contact your healthcare provider promptly.
Recent Reports Link Ozempic to Vision Loss
verywellhealth.com —Another Study Links Ozempic to a Rare Eye Condition That Can Cause Vision Loss
Comments